| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/14/2001 | CN1061885C Specific infusion for hepatitis B and its producting process |
| 02/14/2001 | CN1061875C Traditional chinese medicine for curing chronic constipation |
| 02/14/2001 | CN1061869C Treatment preparation for treating hepatitis B |
| 02/14/2001 | CN1061857C Powder for curing toothache |
| 02/14/2001 | CN1061853C Traditional chinese medicine preparation for treating lithiasis diseases by external application |
| 02/13/2001 | US6187817 Preventing or reducing ototoxicity in a human, cat or dog by administering d-methionine free of the l-isomer |
| 02/13/2001 | US6187798 Heterocyclic compounds |
| 02/13/2001 | US6187778 4-aminopyrrole (3, 2-D) pyrimidines as neuropeptide Y receptor antagonists |
| 02/13/2001 | US6187777 Pyrrolo(3,2-d)pyrimidine derivatives; neuropeptide y and corticotropin releasing factor modulators; dietetics; antidiabetic, antiinflammatory, and antitumor agents |
| 02/13/2001 | US6187545 Oligonucleotide sequences associated with the suppression of the activity of phosphenolpyruvate carboxykinase |
| 02/13/2001 | US6187295 Methods of reducing the astringency of stannous in dentifrice compositions |
| 02/13/2001 | CA2055506C Composition and method for reducing gastro-intestinal distress due to alpha-d-galactoside-linked/containing sugars |
| 02/13/2001 | CA2006713C Packaged anti-plaque oral compositions |
| 02/10/2001 | WO2001032871A2 Follistatin-related protein zfsta4 |
| 02/10/2001 | CA2389956A1 Follistatin-related protein zfsta4 |
| 02/08/2001 | WO2001055118A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
| 02/08/2001 | WO2001009328A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 02/08/2001 | WO2001009184A1 Human g-protein coupled receptor |
| 02/08/2001 | WO2001009171A1 Novel tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 02/08/2001 | WO2001009138A2 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | WO2001009121A2 2-pyrazolin-5-ones_as tyrosine kinase inhibitors |
| 02/08/2001 | WO2001009110A1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 02/08/2001 | WO2001009096A2 Potassium channel openers |
| 02/08/2001 | WO2001009090A2 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 02/08/2001 | WO2001009088A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 02/08/2001 | WO2001008699A1 Methods of inhibiting osteoclastogenesis |
| 02/08/2001 | WO2001008679A1 A method to increase the excretion of non-sterol endogenous hydrophobic substances by increasing excretion of fat via the faeces |
| 02/08/2001 | WO2001008677A1 Methods of inhibiting osteoclast activity |
| 02/08/2001 | WO2001008673A1 Calcilytic compounds |
| 02/08/2001 | WO2001008668A2 Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorders |
| 02/08/2001 | WO2000069449A3 Conditioned cell culture medium compositions and methods of use |
| 02/08/2001 | WO2000061161A3 A pharmaceutical formulation useful for the treatment of hepatitis b, hepatitis c and other viral infections of the liver and a process for its preparation |
| 02/08/2001 | WO2000058295A3 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 02/08/2001 | WO2000056737A3 Calanolides for inhibiting btk |
| 02/08/2001 | CA2647796A1 Method of inhibiting osteoclast activity |
| 02/08/2001 | CA2391267A1 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | CA2380644A1 2-pyrazolin-5-ones |
| 02/08/2001 | CA2380354A1 Novel tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 02/08/2001 | CA2380081A1 Calcilytic compounds |
| 02/08/2001 | CA2380009A1 Methods of inhibiting osteoclastogenesis |
| 02/08/2001 | CA2380007A1 Methods of inhibiting osteoclast activity |
| 02/08/2001 | CA2379360A1 Human g-protein coupled receptor |
| 02/08/2001 | CA2378936A1 Potassium channel openers |
| 02/08/2001 | CA2378710A1 Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorders |
| 02/08/2001 | CA2345753A1 A method to increase the excretion of non-sterol endogenous hydrophobic substances by increasing excretion of fat via the faeces |
| 02/07/2001 | EP1074620A1 Monomeric protein of the TGF-beta family |
| 02/07/2001 | EP1074618A2 Cadherin materials and methods |
| 02/07/2001 | EP1074268A1 Preventives or remedies for inflammatory intestinal diseases containing as the active ingredient il-6 antagonists |
| 02/07/2001 | EP1074257A1 2,7-Substituted octahydro-1H-pyrido (1,2-A)pyrazine derivatives as ligands for serotonin receptors |
| 02/07/2001 | EP1073681A1 Cloning of a novel 7tm receptor axor-2 |
| 02/07/2001 | EP1073666A1 Composition for treatment of external secretion disorders except hypolacrimation |
| 02/07/2001 | EP1073658A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 02/07/2001 | EP1073657A1 Imidazo pyridine derivatives which inhibit gastric acid secretion |
| 02/07/2001 | EP1073656A1 Imidazo pyridine derivatives which inhibit gastric acid secretion |
| 02/07/2001 | EP1073653A1 Novel 2-heterocyclically substituted dihydropyrimidines |
| 02/07/2001 | EP1073642A1 The use of dihydropyrimidines as medicaments, and novel substances |
| 02/07/2001 | EP1073639A1 Quinoline derivatives |
| 02/07/2001 | EP1073635A1 Substituted pyrrolidine hydroxamate metalloprotease inhibitors |
| 02/07/2001 | EP1073634A1 Method for producing enantiomer-free n-methyl-n- (1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide |
| 02/07/2001 | EP1073466A1 Solution containing nicotine |
| 02/07/2001 | EP1073462A2 Hepatitis vaccine |
| 02/07/2001 | EP1073452A2 Method for treating cytokine mediated hepatic injury |
| 02/07/2001 | EP1073435A1 Substituted tricyclic pyrazole derivatives with protein kinase activity |
| 02/07/2001 | EP1073434A1 Ccr-3 receptor antagonists |
| 02/07/2001 | EP1073431A1 Use of nmda antagonists for treatment of irritable bowel syndrome |
| 02/07/2001 | EP1073415A1 Pharmaceutical compositions capable of being gelled |
| 02/07/2001 | EP1073414A1 Use of pharmaceutical compositions capable of being gelled in periodontology |
| 02/07/2001 | EP1073408A1 Desensitizing dentifrice containing potassium and tin salts |
| 02/07/2001 | EP1073333A1 S-rabeprazole compositions and methods |
| 02/07/2001 | EP1073332A1 R-rabeprazole compositions and methods |
| 02/07/2001 | EP0696921B1 Veterinary composition containing a proton pump inhibitor |
| 02/07/2001 | CN1283201A K receptor opioid peptides |
| 02/07/2001 | CN1283184A Process for stereo selective synthesis of prostacyclin derivatives |
| 02/07/2001 | CN1283183A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 02/07/2001 | CN1282743A New beta-carbiline compounds, their preparation method and medicine composition conterning same |
| 02/07/2001 | CN1282737A Intermediate product used for preparing substituted quinoline-2-formamide |
| 02/07/2001 | CN1282610A Medicine for treating gastrointestinal diseases and its preparing process |
| 02/07/2001 | CN1282604A Oral liquid for promoting intelligence development, growth and appetitis of children |
| 02/07/2001 | CN1282598A Particles of antidiarrheal Xiangzhu decoction |
| 02/07/2001 | CN1282588A Medicine for curing hepatism and nephrosis |
| 02/07/2001 | CN1282582A Application of allopurinol for medical purpose |
| 02/07/2001 | CN1061658C Tricyclic benzazepine vasopression antagonists |
| 02/07/2001 | CN1061554C Chinese patent drug for treating hepatitis B |
| 02/07/2001 | CN1061553C Ointment for toothache and stomatocase |
| 02/07/2001 | CN1061538C Chinese patent drug for treating gastric disease |
| 02/06/2001 | US6184389 Feature a plurality of functional groups attached to backbone and phosphoramidate sites |
| 02/06/2001 | US6184244 C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/06/2001 | US6184237 Substituted pyridine compounds and methods of use |
| 02/06/2001 | US6184231 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators |
| 02/06/2001 | US6184229 For treatment of disorders associated with the disfunctioning of nicotinic receptors |
| 02/06/2001 | US6184227 Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
| 02/06/2001 | US6184226 Antiinflammatory agents for treatment of cardiovascular system disorders/respiratory system disorders, antiischemic agents |
| 02/06/2001 | US6184223 Reverse-turn mimetics and methods relating thereto |
| 02/06/2001 | US6184221 Antiarrhythmia agents, antiulcer agents |
| 02/06/2001 | US6184217 Administering antiinflammatory dosage of a ring-substituted indolocarbazole derivative compound; tumor necrosis factor (tnf) inhibitors |
| 02/06/2001 | US6183993 Complement-resistant non-mammalian DNA viruses and uses thereof |
| 02/06/2001 | US6183784 A plurality of cell growth stimulating factors, extracted from milk product, in concentrated form. cell culture compositions and pharmaceutical or veterinary compositions including the above milk product extract. |
| 02/06/2001 | US6183780 May be used for the application of active substances whenever a certain lag-time before release is advantageous, such as in be the case of anti-asthmatics, anti-emetics, cardiotonics, vasodilators, anti-vertigo and anti-meniere. |
| 02/06/2001 | US6183776 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 02/06/2001 | US6183775 Buccal delivery system |